Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $25,275 | 10 | 50.7% |
| Travel and Lodging | $16,197 | 17 | 32.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,870 | 11 | 9.8% |
| Food and Beverage | $3,528 | 107 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $46,556 | 68 | $0 (2020) |
| Medtronic, Inc. | $2,251 | 12 | $0 (2024) |
| AbbVie Inc. | $150.46 | 7 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $135.32 | 10 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $106.03 | 8 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $90.63 | 6 | $0 (2020) |
| Genentech USA, Inc. | $72.26 | 6 | $0 (2017) |
| Auris Health, Inc. | $66.00 | 1 | $0 (2018) |
| Haemonetics Corporation | $54.68 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.27 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,109 | 5 | Medtronic, Inc. ($1,109) |
| 2023 | $756.58 | 7 | Medtronic, Inc. ($683.70) |
| 2022 | $115.97 | 5 | ABBVIE INC. ($115.97) |
| 2021 | $489.27 | 4 | Medtronic, Inc. ($458.21) |
| 2020 | $2,829 | 16 | Covidien LP ($2,700) |
| 2019 | $5,579 | 26 | Covidien LP ($5,311) |
| 2018 | $10,940 | 28 | Covidien LP ($10,696) |
| 2017 | $28,053 | 54 | Covidien LP ($27,849) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/14/2024 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Interventional Lung Solutions | ||||||
| 04/13/2024 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Interventional Lung Solutions | ||||||
| 04/12/2024 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Interventional Lung Solutions | ||||||
| 03/12/2024 | Medtronic, Inc. | ILLUMISITE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 03/12/2024 | Medtronic, Inc. | ILLUMISITE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $430.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 12/20/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Interventional Lung Solutions | ||||||
| 12/15/2023 | Haemonetics Corporation | TEG6S HEMOSTASIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $54.68 | General |
| Category: DEVICES | ||||||
| 11/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 06/08/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Interventional Lung Solutions | ||||||
| 03/07/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $2.98 | General |
| Category: Interventional Lung Solutions | ||||||
| 01/10/2023 | Medtronic, Inc. | ILLUMISITE (Device) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: Interventional Lung Solutions | ||||||
| 11/22/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2021 | Cumberland Pharmaceuticals, Inc. | VAPRISOL DEXTROSE IN PLASTIC CONTAINER (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2021 | Medtronic, Inc. | ILLUMISITE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 03/05/2021 | Medtronic, Inc. | superDimension (Device) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: Interventional Lung Solutions | ||||||
| 11/05/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2020 | Covidien LP | superDimension (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 10/27/2020 | Covidien LP | superDimension (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Interventional Lung Solutions | ||||||
| 10/27/2020 | Covidien LP | superDimension (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Interventional Lung Solutions | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 635 | 699 | $392,742 | $53,710 |
| 2022 | 17 | 1,052 | 1,157 | $556,494 | $71,195 |
| 2021 | 20 | 1,160 | 1,353 | $729,730 | $88,172 |
| 2020 | 18 | 1,280 | 1,516 | $1.2M | $123,025 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 146 | 146 | $52,122 | $13,913 | 26.7% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 68 | 68 | $127,500 | $11,386 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 105 | 126 | $29,232 | $8,691 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 66 | $18,744 | $6,624 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 105 | 141 | $26,085 | $5,975 | 22.9% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 31 | 33 | $29,436 | $2,891 | 9.8% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 36 | 37 | $101,676 | $2,718 | 2.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 17 | $2,482 | $1,045 | 42.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 19 | 19 | $3,648 | $170.74 | 4.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 25 | 25 | $725.00 | $167.35 | 23.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 21 | 21 | $1,092 | $129.07 | 11.8% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2022 | 84 | 84 | $157,500 | $14,192 | 9.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 139 | 139 | $49,623 | $13,144 | 26.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 79 | 81 | $23,004 | $8,430 | 36.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 97 | $24,832 | $7,815 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 121 | 164 | $30,301 | $7,449 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 56 | 61 | $14,152 | $4,493 | 31.7% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2022 | 49 | 49 | $43,708 | $3,674 | 8.4% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2022 | 47 | 47 | $129,156 | $3,582 | 2.8% |
| 31626 | Placement of radiation therapy markers into lung airways using an endoscope | Facility | 2022 | 22 | 22 | $31,237 | $2,010 | 6.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 28 | $4,088 | $1,557 | 38.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 109 | 109 | $20,928 | $1,043 | 5.0% |
| 31625 | Biopsy of lung airway using an endoscope | Facility | 2022 | 16 | 16 | $12,832 | $920.02 | 7.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 111 | 111 | $3,219 | $787.34 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 16 | 16 | $3,680 | $766.11 | 20.8% |
About Dr. Mark Bowling, MD
Dr. Mark Bowling, MD is a Internal Medicine healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710914098.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bowling, MD has received a total of $49,871 in payments from pharmaceutical and medical device companies, with $1,109 received in 2024. These payments were reported across 145 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($25,275).
As a Medicare-enrolled provider, Bowling has provided services to 4,127 Medicare beneficiaries, totaling 4,725 services with total Medicare billing of $336,102. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Greenville, NC
- Active Since 06/26/2006
- Last Updated 02/01/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1710914098
Products in Payments
- superDimension (Device) $35,868
- SuperDimension (Device) $10,592
- ILLUMISITE (Device) $2,243
- VRAYLAR (Drug) $176.99
- KEYTRUDA (Biological) $108.82
- OPDIVO (Biological) $92.47
- TEG6S HEMOSTASIS SYSTEM (Device) $54.68
- IMFINZI (Drug) $54.67
- GILOTRIF (Drug) $51.27
- Avastin (Biological) $50.86
- TRULICITY (Drug) $39.09
- TAGRISSO (Drug) $35.96
- TASIGNA (Drug) $33.27
- TECENTRIQ (Biological) $21.40
- Prolastin-C (Biological) $19.59
- ZEJULA (Drug) $19.29
- Abraxane (Drug) $18.92
- ACTHAR (Biological) $18.16
- TUDORZA PRESSAIR (Drug) $16.93
- LENVIMA (Drug) $16.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greenville
Stephen Dyar, Md, MD
Internal Medicine — Payments: $381,835
Dr. John Catanzaro, Md, MD
Internal Medicine — Payments: $331,996
Bhumika Patel, M.d, M.D
Internal Medicine — Payments: $208,547
Dr. Thomas Gallaher, M.d, M.D
Internal Medicine — Payments: $208,355
Bruce Gray, D.o, D.O
Internal Medicine — Payments: $166,102
Dr. Mark Purcell, Do, DO
Internal Medicine — Payments: $135,587